DK1023314T3 - Galdesyredsalte af metaller med fysiologisk virkning og anvendelsen deraf ved terapi - Google Patents

Galdesyredsalte af metaller med fysiologisk virkning og anvendelsen deraf ved terapi

Info

Publication number
DK1023314T3
DK1023314T3 DK97909372T DK97909372T DK1023314T3 DK 1023314 T3 DK1023314 T3 DK 1023314T3 DK 97909372 T DK97909372 T DK 97909372T DK 97909372 T DK97909372 T DK 97909372T DK 1023314 T3 DK1023314 T3 DK 1023314T3
Authority
DK
Denmark
Prior art keywords
bile acid
therapy
metals
acid salts
physiological effect
Prior art date
Application number
DK97909372T
Other languages
English (en)
Inventor
Beniamino Palmieri
Alessandro Medici
Enzo Bartoli
Original Assignee
Ice Srl
Beniamino Palmieri
Alessandro Medici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ice Srl, Beniamino Palmieri, Alessandro Medici filed Critical Ice Srl
Application granted granted Critical
Publication of DK1023314T3 publication Critical patent/DK1023314T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97909372T 1997-10-09 1997-10-09 Galdesyredsalte af metaller med fysiologisk virkning og anvendelsen deraf ved terapi DK1023314T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/005555 WO1999019342A1 (en) 1997-10-09 1997-10-09 Bile acid salts of metals with physiological action and the use thereof in therapy

Publications (1)

Publication Number Publication Date
DK1023314T3 true DK1023314T3 (da) 2003-05-12

Family

ID=8166756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97909372T DK1023314T3 (da) 1997-10-09 1997-10-09 Galdesyredsalte af metaller med fysiologisk virkning og anvendelsen deraf ved terapi

Country Status (14)

Country Link
US (1) US6342489B1 (da)
EP (1) EP1023314B1 (da)
JP (1) JP2001519438A (da)
AT (1) ATE232541T1 (da)
AU (1) AU747019B2 (da)
CA (1) CA2305764C (da)
DE (1) DE69719095T2 (da)
DK (1) DK1023314T3 (da)
ES (1) ES2191825T3 (da)
HK (1) HK1032064A1 (da)
IL (2) IL135499A0 (da)
NO (1) NO314761B1 (da)
NZ (1) NZ503800A (da)
WO (1) WO1999019342A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
WO2012097155A1 (en) * 2011-01-14 2012-07-19 Chiasma Inc. Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1468922A1 (de) * 1965-06-30 1969-06-19 Riedel De Haen Ag Verfahren zur Herstellung choleretisch wirksamer Derivate der 3-alpha-Hydroxy-7,12-diketocholansaeure
US3620831A (en) * 1968-12-30 1971-11-16 Honeywell Inc Electrographic recording medium
GB1592791A (en) * 1977-01-07 1981-07-08 Radiochemical Centre Ltd Selenium- or tellurium-containing bile acids and derivatives thereof
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5174897A (en) * 1991-09-24 1992-12-29 The United States Of America As Represented By The Secretary Of Agriculture Constructed wetlands to control nonpoint source pollution
US5460812A (en) 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5415872A (en) 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5578304A (en) 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
CA2305764C (en) 2008-04-08
NZ503800A (en) 2001-03-30
ATE232541T1 (de) 2003-02-15
IL135499A0 (en) 2001-05-20
CA2305764A1 (en) 1999-04-22
EP1023314B1 (en) 2003-02-12
ES2191825T3 (es) 2003-09-16
NO314761B1 (no) 2003-05-19
JP2001519438A (ja) 2001-10-23
NO20001812D0 (no) 2000-04-07
WO1999019342A1 (en) 1999-04-22
DE69719095D1 (de) 2003-03-20
DE69719095T2 (de) 2003-07-24
US6342489B1 (en) 2002-01-29
IL135499A (en) 2006-10-31
AU747019B2 (en) 2002-05-09
EP1023314A1 (en) 2000-08-02
HK1032064A1 (en) 2001-07-06
AU4708197A (en) 1999-05-03
NO20001812L (no) 2000-04-07

Similar Documents

Publication Publication Date Title
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DK0415850T3 (da) Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
WO2002085299A3 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DK0445255T4 (da) Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
HUP0301101A3 (en) Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
ATE170077T1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
DE69629570D1 (de) 3'utr des menschliches prohibitin-gens
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
DK1023314T3 (da) Galdesyredsalte af metaller med fysiologisk virkning og anvendelsen deraf ved terapi
HK1045524A1 (en) 5-Hydroxysapogenin derivatives with anti-dementia activity
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
TR199901385T2 (xx) Piperidin t�revleri.
EA200200656A1 (ru) НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-е]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ
GB9723824D0 (en) Cytostatic agents
PT1150981E (pt) Composto nucleosidico terapeutico
RU94024641A (ru) Способ лечения противовоспалительных процессов